• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Impact of the coronavirus 2019 (COVID-19) on vasooclusive crisis in patients with sickle cell anaemia

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2021 Mar 16;S1201-9712(21)00262-9.
doi: 10.1016/j.ijid.2021.03.044. Online ahead of print.
Impact of the coronavirus 2019 (COVID-19) on vasooclusive crisis in patients with sickle cell anaemia


S Alkindi[SUP] 1 [/SUP], R A Elsadek[SUP] 2 [/SUP], A Al-Madhani[SUP] 3 [/SUP], M Al-Musalhi[SUP] 4 [/SUP], S Y AlKindi[SUP] 5 [/SUP], G Al-Khadouri[SUP] 6 [/SUP], B Al Rawahi[SUP] 6 [/SUP], S Al-Ruqeishi[SUP] 6 [/SUP], J Al-Yazeedi[SUP] 7 [/SUP], Y A Wali[SUP] 8 [/SUP], S Al Shamakhi[SUP] 9 [/SUP], M Al Rawahi[SUP] 10 [/SUP], A V Pathare[SUP] 11 [/SUP]



Affiliations

Abstract

Objectives: The aim of this study was to assess the impact of COVID-19 on the morbidity and mortality on vasooclusive crisis (VOC) in sickle cell anaemia (SCA) patients.
Methods: One hundred patients with(fifty) or without COVID-19 PCR positivity(fifty), were enrolled in a prospective cohort study after signing a written informed consent.
Results: The COVID-19 positive patients had significantly higher median VOC episodes/year i.e 3 /year (IQR, 1-6 /year) v/s 2 /year (IQR, 2-12 /year) (p < 0.05) respectively, however the need for hospitalization was similar. There was a higher culture proven infection in COVID-19 negative group (P = 0.05). COVID-19 positive group had more osteonecrosis (p < 0.05), splenic sequestration, splenomegaly, and hepatic crisis (P values 0.05, 0.006 and 0.02 respectively). Symptoms of fever, cough, fatigue, abdominal pain and anosmia were significantly higher (p < 0.05) in the COVID-19 positive patients. Both cohorts, showed a fall in the mean haemoglobin, lymphocyte subset, platelets, and reticulocytes, whereas, the LDH and ferritin were significantly elevated. In SCA COVID-19 positive patients the rise in WBC, reticulocyte%, platelets, and ferritin was subdued (p < 0.05). Two died in COVID-19 positive, whereas three died in the COVID-19 negative, without statistically significant difference in mortality.
Conclusions: Although COVID-19 infection may have triggered the onset of VOC, it did not significantly influence the morbidity or mortality in this SCA cohort.

Keywords: COVID-19; Coronavirus; SCA; Sickle cell anaemia; Vasooclusive crises.
 
Back
Top Bottom